Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W van Oosten

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Journal of Neurology|January 23, 2009
Steroid-responsive edema in CAA-related inflammationRichard Daniëls, Jeroen J G Geurts, Joost C Bot, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 22, 2004
[Eyelid drooping: diagnosis on the basis of an algorithm]B W van Oosten, C J de Langen, G Tissingh, et al.
Neurology|August 1, 1997
Interleukin-2 therapy does not exacerbate multiple sclerosisB W van Oosten, B M Uitdehaag, F Barkhof, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 12, 2015
[Progressive cognitive disturbances in a 17-year-old boy]Dagmar H Hepp, Karin van Dijk, Cornelis J Stam, et al.
Journal of Neurology|October 10, 2014
Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literatureMartijn T Wijburg, Bob W van Oosten, Jean-Luc Murk, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 19, 2026
Reinitiating ocrelizumab with a full 600 mg dose after extended treatment interruption: No increased risk of infusion-related reactionsLisa G Schoof, Laura Hogenboom, Zoé LE van Kempen, et al.
Neurology|October 5, 2012
Tumefactive multiple sclerosis lesions under fingolimod treatmentFemke Visser, Mike P Wattjes, Petra J W Pouwels, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 25, 2019
[Paroxysmal hypothermia in multiple sclerosis]F G C M De Kleermaeker, Bernard M J Uitdehaag, Bob W van Oosten, et al.
Archives of Neurology|June 17, 1998
Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosisB W van Oosten, F Barkhof, P E Scholten, et al.
Multiple Sclerosis and Related Disorders|February 17, 2020
A tumefactive demyelinating lesion in a person with MS after five years of fingolimodL Jeung, L M G Smits, E L J Hoogervorst, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Journal of Neurology|January 23, 2009
Steroid-responsive edema in CAA-related inflammationRichard Daniëls, Jeroen J G Geurts, Joost C Bot, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 22, 2004
[Eyelid drooping: diagnosis on the basis of an algorithm]B W van Oosten, C J de Langen, G Tissingh, et al.
Neurology|August 1, 1997
Interleukin-2 therapy does not exacerbate multiple sclerosisB W van Oosten, B M Uitdehaag, F Barkhof, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 12, 2015
[Progressive cognitive disturbances in a 17-year-old boy]Dagmar H Hepp, Karin van Dijk, Cornelis J Stam, et al.
Journal of Neurology|October 10, 2014
Heterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literatureMartijn T Wijburg, Bob W van Oosten, Jean-Luc Murk, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 19, 2026
Reinitiating ocrelizumab with a full 600 mg dose after extended treatment interruption: No increased risk of infusion-related reactionsLisa G Schoof, Laura Hogenboom, Zoé LE van Kempen, et al.
Neurology|October 5, 2012
Tumefactive multiple sclerosis lesions under fingolimod treatmentFemke Visser, Mike P Wattjes, Petra J W Pouwels, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 25, 2019
[Paroxysmal hypothermia in multiple sclerosis]F G C M De Kleermaeker, Bernard M J Uitdehaag, Bob W van Oosten, et al.
Archives of Neurology|June 17, 1998
Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosisB W van Oosten, F Barkhof, P E Scholten, et al.
Multiple Sclerosis and Related Disorders|February 17, 2020
A tumefactive demyelinating lesion in a person with MS after five years of fingolimodL Jeung, L M G Smits, E L J Hoogervorst, et al.
Pageof 8